20 Results for "

teratocarcinoma

" in MedChemExpress (MCE) Product Catalog:
Products (20)

20 Results for "teratocarcinoma" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-15313C
CAS No.: 2070015-03-9
Purity:  97.08%
Target:  

Histone Demethylase

Research Areas:  

Metabolic Disease Cancer

CBB1007 trihydrochloride is a reversible and selective LSD1 inhibitor with an IC50 of 5.27 µM for human LSD1. CBB1007 trihydrochloride significantly blocks the demethylase activity of LSD1 on H3K4Me2 and H3K4Me. CBB1007 trihydrochloride shows selectivity for LSD1 over LSD2 or JARID1A, and induces differentiation-related genes in pluripotent cells. CBB1007 trihydrochloride is studied in non-pluripotent cancer research, targeting teratocarcinoma, embryonic carcinoma, and seminoma .
loading...
    loading...
Cat. No.: HY-156209
CAS No.: 137896-85-6
Research Areas:  

Cardiovascular Disease Cancer

Gb3 (d18:1/16:0) (Compound 1) is the P k antigen of the P blood group system. Gb3 (d18:1/16:0) acts as a cell surface receptor. Gb3 (d18:1/16:0) is used for research on Burkitt's lymphoma, teratocarcinoma, embryonal carcinoma, and Fabry's disease .
loading...
    loading...
Cat. No.: HY-177733
Research Areas:  

Cancer

MG-Lin3 is a Lin28 molecular glue degrader. MG-Lin3 recruits the E3 ubiquitin ligase RNF126 to form a ternary complex, induces the degradation of Lin28 via the ubiquitin-proteasome pathway, and restores the levels of mature let-7 miRNA. MG-Lin3 can be used in research on ovarian cancer, ovarian teratocarcinoma, and uterine cancer .
loading...
    loading...
Cat. No.: HY-156209S
CAS No.: 2738376-84-4
Gb3(d18:1/16:0)-d9 is deuterium labeled Gb3(d18:1/16:0) (HY-156209). Gb3 (d18:1/16:0) (Compound 1) is the P k antigen of the P blood group system. Gb3 (d18:1/16:0) acts as a cell surface receptor. Gb3 (d18:1/16:0) is used for research on Burkitt's lymphoma, teratocarcinoma, embryonal carcinoma, and Fabry's disease .
loading...
    loading...
Cat. No.: HY-169730
CAS No.: 1385817-77-5
Target:  

Wnt

Research Areas:  

Cancer

Wnt pathway inhibitor 5 (Compound 28) is wnt pathway inhibitor, with an IC50 value of < 0.003 μΜ. Wnt pathway inhibitor 5 inhibits many cancers, including ovarian teratocarcinoma cancer, breast cancer, osteosarcoma, head and neck squamous carcinoma .
loading...
    loading...
Cat. No.: HY-15313B
CAS No.: 2070014-96-7
Purity:  ≥98.0%
Target:  

Histone Demethylase

Research Areas:  

Metabolic Disease Cancer

CBB1007 hydrochloride is a reversible and selective LSD1 inhibitor with an IC50 of 5.27 µM for human LSD1. CBB1007 hydrochloride significantly blocks the demethylase activity of LSD1 on H3K4Me2 and H3K4Me. CBB1007 hydrochloride shows selectivity for LSD1 over LSD2 or JARID1A, and induces differentiation-related genes in pluripotent cells. CBB1007 hydrochloride is studied in  non-pluripotent cancer research, targeting teratocarcinoma, embryonic carcinoma, and seminoma .
loading...
    loading...
Cat. No.: HY-15313
CAS No.: 1379573-92-8
Target:  

Histone Demethylase

Research Areas:  

Metabolic Disease Cancer

CBB1007 is a reversible and selective LSD1 inhibitor with an IC50 of 5.27 µM for human LSD1. CBB1007 significantly blocks the demethylase activity of LSD1 on H3K4Me2 and H3K4Me. CBB1007 shows selectivity for LSD1 over LSD2 or JARID1A, and induces differentiation-related genes in pluripotent cells. CBB1007 is studied in non-pluripotent cancer research, targeting teratocarcinoma, embryonic carcinoma, and seminoma .
loading...
    loading...
Cat. No.: HY-P700489
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: CRIPTO3; teratocarcinoma-Derived Growth Factor 3; Prev. TDGF1P3; Protein CRIPTO3; Prev. TDGF3; teratocarcinoma-Derived Growth Factor 2 (Retroposin, Possibly Expressed); CRIPTO-3; teratocarcinoma-Derived Growth Factor 3, Pseudogene; TDGF2; Putative Teratoc
Species:  
Human
Source:  
P. pastoris
loading...
    loading...
Cat. No.: HY-P810818
Synonyms: TC21, RRAS2, Ras-related protein R-Ras2, Ras-like protein TC21, teratocarcinoma oncogene

Host:  

Mouse

Application:  

WB

Reactivity:  

Human, Mouse

loading...
    loading...
Cat. No.: HY-P85107
Synonyms: TDGF1; CRIPTO; teratocarcinoma-derived growth factor 1; Cripto-1 growth factor; CRGF; Epidermal growth factor-like cripto protein CR1

Host:  

Mouse

Application:  

WB, ELISA

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-P701974
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: RRAS2; Ras-Related Protein R-Ras2; RAS Related 2; teratocarcinoma Oncogene; TC21; Ras-Like Protein TC21; Related RAS Viral (R-Ras) Oncogene Homolog 2; NS12
Species:  
Human
Source:  
E. coli
loading...
    loading...
Cat. No.: HY-P701975
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: RRAS2; Ras-Related Protein R-Ras2; RAS Related 2; teratocarcinoma Oncogene; TC21; Ras-Like Protein TC21; Related RAS Viral (R-Ras) Oncogene Homolog 2; NS12
Species:  
Human
Source:  
E. coli
loading...
    loading...
Cat. No.: HY-P700481
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: CRIPTO; Cripto-1 Growth Factor; Prev. TDGF1; Cripto-1; teratocarcinoma-Derived Growth Factor 1; CRGF; CR-1; Growth Factor; CR; CRIPTO-1; Epidermal Growth Factor-Like Cripto Protein CR1; Cripto, EGF-CFC Family Member; Protein Cripto
Species:  
Human
Source:  
E. coli
loading...
    loading...
Cat. No.: HY-P71112
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: CRIPTO; Cripto-1 Growth Factor; Prev. TDGF1; Cripto-1; teratocarcinoma-Derived Growth Factor 1; CRGF; CR-1; Growth Factor; CR; CRIPTO-1; Epidermal Growth Factor-Like Cripto Protein CR1; Cripto, EGF-CFC Family Member; Protein Cripto
Species:  
Human
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P703895
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: CRIPTO; Cripto-1 Growth Factor; Prev. TDGF1; Cripto-1; teratocarcinoma-Derived Growth Factor 1; CRGF; CR-1; Growth Factor; CR; CRIPTO-1; Epidermal Growth Factor-Like Cripto Protein CR1; Cripto, EGF-CFC Family Member; Protein Cripto
Species:  
Human
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P702506
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: CRIPTO; Cripto-1 Growth Factor; Prev. TDGF1; Cripto-1; teratocarcinoma-Derived Growth Factor 1; CRGF; CR-1; Growth Factor; CR; CRIPTO-1; Epidermal Growth Factor-Like Cripto Protein CR1; Cripto, EGF-CFC Family Member; Protein Cripto
Species:  
Mouse
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P75329
Purity:  ≥ 80%, as determined by reducing SDS-PAGE.
Synonyms: CRIPTO; Cripto-1 Growth Factor; Prev. TDGF1; Cripto-1; teratocarcinoma-Derived Growth Factor 1; CRGF; CR-1; Growth Factor; CR; CRIPTO-1; Epidermal Growth Factor-Like Cripto Protein CR1; Cripto, EGF-CFC Family Member; Protein Cripto
Species:  
Rat
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P75330
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: CRIPTO; Cripto-1 Growth Factor; Prev. TDGF1; Cripto-1; teratocarcinoma-Derived Growth Factor 1; CRGF; CR-1; Growth Factor; CR; CRIPTO-1; Epidermal Growth Factor-Like Cripto Protein CR1; Cripto, EGF-CFC Family Member; Protein Cripto
Species:  
Rat
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-124616
CAS No.: 1639358-50-1
Research Areas:  

Cancer

CBB3001 is an inhibitor of LSD1/KDM1A. CBB3001 exerts its effect by inhibiting Histone Demethylase activity, with an IC50 of 21.25 μM. It downregulates the expression of pluripotency-related proteins and genes such as SOX2 and OCT4, and induces cell differentiation, growth arrest, and apoptosis. CBB3001 can be used for research on testicular germ cell tumors, teratomas, and embryonal carcinomas .
loading...
    loading...
Cat. No.: HY-114178
CAS No.: 1879980-97-8
Research Areas:  

Cancer

CDK8-IN-2 is an orally active CDK8 inhibitor of an IC50 values of 0.010 μM. CDK8-IN-2 shows a CDK19 IC50 value of 0.026 μM. CDK8-IN-2 inhibits phospho-STAT1, a pharmacodynamic biomarker of CDK8. CDK8-IN-2 inhibits WNT pathway activity. CDK8-IN-2 can be used for the research of colorectal carcinoma .
loading...
    loading...
  • 1